I received a couple of reader questions in recent weeks that I’d like to answer here, in the hopes that my responses will be more broadly helpful. The questions cover COVID-19’s incubation period (i.e. time between exposure and symptoms), vaccine effectiveness for this fall, and nasal sprays.
After two months of consistent increases in major COVID-19 metrics, we have once again reached, “Has the surge peaked?” territory. Preliminary data from wastewater and testing are suggesting potential plateaus, while more people are still getting hospitalized with COVID-19.
In May 2023, the Department of Health and Human Services (HHS), Walgreens, and Labcorp started offering free PCR tests at select pharmacy locations. The program appears to still be available following the end of the federal public health emergency.
Overall, the national COVID-19 picture remains fairly similar to what we’ve seen for the last few weeks. The U.S. is at a plateau of COVID-19 spread; we could see an increase this summer, but limited data make it hard to say for sure.
The COVID-19 plateau of the last few weeks continues at the national level, though experts are concerned that a summer surge could occur in parts of the country. Wastewater surveillance and testing data are indicating potential increases in the New York City region.
We’re now less than one week out from May 11, when the federal public health emergency (or PHE) for COVID-19 will end. While this change doesn’t actually signify that COVID-19 is no longer worth worrying about, it marks a major shift in how U.S. governments will respond to the ongoing pandemic, including how the disease is tracked and what public services are available. Here’s all the key info you should know about this, in one place.
Major COVID-19 metrics continue to suggest an ongoing (though slight) decline in the virus’ spread nationally, despite the rise of newer and more contagious variants. The moderate plateau persists.